Boully, Clémence
,
Vidal, Jean-Sébastien
Guibert, Etienne
Ghazali, Fanny Nisrin
Pesce, Alain
Beauplet, Bérengère
Roger, Jean-Dominique
Carrière, Isabelle
Timbely, Boubacar
Idiri, Houria
Constensoux, Jean-Pierre
Durocher, Anne-Marie
Dubail, Delphine
Fargier, Marc
Jeandel, Claude
Berrut, Gilles
Hanon, Olivier
Funding for this research was provided by:
Société Française de Gériatrie et Gérontologie
Article History
Received: 18 January 2019
Accepted: 16 July 2019
First Online: 1 August 2019
Ethics approval and consent to participate
: The study was conducted in accordance with the ethical standards set forth in the Declaration of Helsinki (1983). The entire study protocol was approved by the ethics committee of Nantes (Groupe Nantais d’Ethique dans le Domaine de la Santé, France), and the study complies with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement guidelines.No consent to participate was sought for the subjects in accordance to the French ethics rules because the study was observational (related to usual care), and no nominative data were collected (Code de la Santé Publique – Article L1121–1. ExternalRef removed). All patients’ data were anonymized at the patients’ sites before they were uploaded to the study center.
: N/A
: OH received consultant/advisory/lecture fees from Bayer, Boehringer-Ingelheim, BMS, Pfizer, Novartis, Servier, Astra-Zeneca, Vifor.CJ received consultant/advisory/lecture fees from Bayer, Boehringer-Ingelheim, BMS, Pfizer, Novartis, Servier, Vifor.GB received consultant/advisory/lecture fees from Bayer, BMS, Pfizer, Novartis, Vifor.CB, JSV, EG, FNG, AP, BB, JDR, IC, BT, HI, JPC, AMD, DD, MF have no competing interests.